SCHEMBL8286643

SCHEMBL8286643

CCC/C=C(\C)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1485553 1.00
Hydrochloric Acid SCHEMBL29156657 0.97
SCHEMBL1485758 0.82
SCHEMBL19999905 0.82
SCHEMBL1556986 0.80
SCHEMBL1556987 0.80
SCHEMBL22599146 0.80
SCHEMBL23273616 0.78 EP300 (0.50)
SCHEMBL15263795 0.78 EP300 (0.50)
SCHEMBL23273617 0.78 EP300 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3165925-B1 METHODS FOR THE DIAGNOSIS OF COLORECTAL CANCER MED LIFE DISCOVERIES LP (CA) 2021-09-08 EP disclosed
EP-3165925-A1 METHODS FOR THE DIAGNOSIS OF COLORECTAL CANCER AND OVARIAN CANCER HEALTH STATES Phenomenome Discoveries Inc. (CA) 2017-05-10 EP disclosed
US-9593080-B1 Triazabutadienes as cleavable cross-linkers THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2017-03-14 US disclosed
EP-2646043-B1 NOVEL CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF A VIRAL INFECTION S&T GLOBAL INC (US) 2017-02-15 EP disclosed
EP-2140862-A2 Use of GAL 3 receptor antagonists for the treatment of depression and /or anxiety and compounds useful in such methods H.Lundbeck A/S (DK) 2010-01-06 EP disclosed
WO-2005051934-A1 ANTITHROMBOTIC COMPOUNDS WITH DUAL FUNCTION UNIVERSITY OF LJUBLJANA (SI) 2005-06-09 WO disclosed